Lupin has entered into a Business Transfer Agreement (BTA) with Lupin Manufacturing Solutions (LMSL), wholly owned subsidiary of the Company, to carve out two Active Pharmaceutical Ingredients (API) manufacturing sites situated at Dabhasa and Visakhapatnam and select R&D operations, including fermentation, at Lupin Research Park, Pune. Earlier, the company had received approval from board of directors to enter into a business transfer agreement.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
